PDL, botulinumtoxinA improves rosacea symptoms
October 22, 2020

Treatment with a pulsed dye laser followed immediately by intradermal botulinumtoxinA injections appears safe and improved erythema, flushing, burning and pruritus, according to a recent study.

Phenotype-based approach advances management
October 16, 2020

The 21-member global ROSacea Consensus panel developed updated recommendations for rosacea, diagnosis, classification and management to support and promote transition to a phenotype approach in rosacea.

Misinformation delays rosacea diagnosis in skin of color patients
October 16, 2020

The idea that rosacea is uncommon in darker skinned individuals may be due to under-recognition. Careful clinical examination, a thorough history and biopsy in some cases are needed for accurate diagnosis and differentiating rosacea from diseases that may be more common.

Topical minocycline for rosacea now available
October 01, 2020

ZILXI (FMX103, VYNE Therapeutics), a 1.5% topical minocycline foam, is now available for prescription for the treatment of inflammatory lesions of rosacea in adult patients.

FDA accepts NDA filing for topical papulopustular rosacea treatment
September 14, 2020

The U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) filing for Sol-Gel’s Epsolay, a 5% microencapsulated benzoyl peroxide cream for the treatment of inflammatory lesions of rosacea or papulopustular rosacea.

Phenotypes inform management options
August 20, 2020

Many patients with rosacea have features that overlap more than one subtype of the condition. A recent publication serves as a compliment to the classification guide with the intention of guiding treatment and management options based on individual patient features.

Specialized skincare regimen improves rosacea symptoms
August 14, 2020

Effects of a specialized skincare regimen for sensitive and redness-prone skin were investigated in an eight-week, prospective, controlled clinical trial enrolling 60 patients with rosacea. The intervention was associated with improvements in objectively measured erythema, rosacea symptoms, and health-related quality of life.

Pathophysiologic pathways provide treatment efficacy insight
August 11, 2020

Experts offer insights into the inflammatory pathways involved in rosacea pathogenesis, the putative anti-inflammatory mechanisms of action of treatments for rosacea, and future therapeutic needs.

Pilot study examines facial microbiome diversity
July 29, 2020

A study in twins highlights exacerbating factors for patients with rosacea and the importance of the microbiome.

Topical minocycline foam safe, well-tolerated
July 28, 2020

A topical minocycline foam application appears effective and was well-tolerated by patients with moderate-to-severe papulopustular rosacea.